Kolumne, ORE

Original-Research: DEMIRE - from NuWays AG Classification of NuWays AG to DEMIRE Company Name: DEMIRE ISIN: DE000A0XFSF0 Reason for the research: Update Recommendation: Halten from: 28.03.2024 Target price: EUR 1.20 Target price on sight of: 12 Monaten Last rating change: Analyst: Philipp Sennewald Mgmt confirms negotiations regarding bond restructuring Topic: DEMIRE released an ad-hoc, stating that the company has entered negotiations with a group of bondholders (Ad hoc Group), which is said to hold "well over 50%' of the outstanding nominal amount, regarding the restructuring of its unsecured corporate bond.

28.03.2024 - 09:02:35

Original-Research: DEMIRE (von NuWays AG): Halten


Original-Research: DEMIRE - from NuWays AG

Classification of NuWays AG to DEMIRE

Company Name: DEMIRE
ISIN: DE000A0XFSF0

Reason for the research: Update
Recommendation: Halten
from: 28.03.2024
Target price: EUR 1.20
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Philipp Sennewald

Mgmt confirms negotiations regarding bond restructuring
 
Topic: DEMIRE released an ad-hoc, stating that the company has entered
negotiations with a group of bondholders (Ad hoc Group), which is said to
hold "well over 50%' of the outstanding nominal amount, regarding the
restructuring of its unsecured corporate bond. Mind you, the corporate bond
is due on 15 October 2024 and has an outstanding nominal amount of EUR 499m
(EUR 600m at issue date). The company also gave indications as to which
points a possible restructuring agreement could contain. In detail:
 
(1) Extension of the term until 31 December 2027 at an increased coupon as
well as additional compensation payments. While the company did not specify
on possible conditions, we estimate total annual costs of 6.5% to be in
line with the market, which would result in additional financial expenses
of c. EUR 23m given the current nominal amount.
 
(2) Mandatory repayments of the bond from the net sales proceeds of future
asset disposals. Considering a net-secured LTV of 12.5%, assets held for
sale to the tune of EUR 160m (as of 9M excl. LogPark), a 20% BV discount and
the net cash inflow from the LogPark sale (eNuW: EUR 65-70m) this figure
could amount to c. EUR 180m in 2024 alone.
 
(3) Obligation to waive dividends or other distributions to shareholders
during the extended term of the bond.
 
(4) Additional collateralization of the bond in favor of the bondholders,
likely via the company's portfolio of unencumbered assets.
 
In addition, the company stated that one member of the Ad hoc Group intends
to dispose a position to the tune of c. 20% of the outstanding nominal
amount or c. EUR 100m. The company further stated that it considers
submitting a bid to acquire the corresponding position. Considering this to
be a highly distressed situation for the seller, DEMIRE would possibly be
able to acquire the position below market levels (64% as of yesterday's
close).
 
Yet, as all the above is still subject to approval of the Ad hoc Group as
well as an external economic feasibility analysis, we keep our forecast
model unchanged for the time being.
 
Given the prevailing uncertainty regarding the investment case, we
reiterate HOLD with a EUR 1.20 PT.

You can download the research here:
http://www.more-ir.de/d/29273.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden: www.nuways-ag.com/research.
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...